Morgan Stanley’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.6M | Buy |
1,868,148
+923,067
| +98% | +$24M | ﹤0.01% | 1961 |
|
|
2025
Q1 | $23.1M | Buy |
945,081
+219,854
| +30% | +$5.38M | ﹤0.01% | 2547 |
|
|
2024
Q4 | $20.8M | Buy |
725,227
+490,356
| +209% | +$14.1M | ﹤0.01% | 2714 |
|
|
2024
Q3 | $8.86M | Buy |
234,871
+140,162
| +148% | +$5.29M | ﹤0.01% | 3526 |
|
|
2024
Q2 | $2.99M | Buy |
94,709
+20,985
| +28% | +$662K | ﹤0.01% | 4294 |
|
|
2024
Q1 | $3.24M | Buy |
+73,724
| New | +$3.24M | ﹤0.01% | 4251 |
|